Skip to main content

2025 IDWeek Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Session Icons

Live Streamed

On Demand

Frank Kung, PhD

Associate Director, Medical Communications
Shionogi Inc

Disclosure(s): Shionogi Inc: Employee

Poster(s):

(P-1310) Cefiderocol Remains Active against US Clinical Isolates of Stenotrophomonas maltophilia Non-susceptible to Comparator Agents: Results from the SENTRY Antimicrobial Surveillance Program (2020–2024)

Tuesday, October 21, 2025
12:15 PM - 1:30 PM US ET